Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases

Current Biology

Volumn 6, Issue 12, 1996, Pages 1628-1633

  Olson, Michael F ^a,c   Pasteris, N German ^b   Gorski, Jerome L ^b   Hall, Alan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0030466893     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)70786-0     Document Type: Article

References (37)

1. Ridley AJ, Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992, 70:389-399.
2. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410.
3. Nobes CD, Hall A: Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell 1995, 81:1-20.
4. Olson MF, Ashworth A, Hall A: An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995, 269:1270-1272.
5. Nishiki T, Narumiya S, Morii N, Yamamoto M, Fujiwara M, Kamata Y, et al.: ADP-ribosylation of the rho/ rac proteins induces growth inhibition, neurite outgrowth and acetylcholine esterase in cultured PC-12 cells. Biochem Biophys Res Commun 1990, 167:265-272.
6. Yamamoto M, Marui N, Sakai T, Morii N, Kozaki S, Ikai K, et al.: ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. J Biol Chem 1993, 268:21509-21512.
7. Minden A, Lin A, Claret FX, Abo A, Karin M: Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995, 81:1147-1157.
8. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, et al.: The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/ SAPK signaling pathway. Cell 1995, 81:1137-1146.
9. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, et al.: Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 1995, 270:23934-23936.
10. Bagrodia S, Derijard B, Davis RJ, Cerione RA: Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J Biol Chem 1995, 270:27995-27998.
11. Hill CS, Wynne J, Treisman R: The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 1995, 81:1159-1170.
12. Cerione RA, Zheng Y: The Dbl family of oncogenes. Curr Op Cell Biol 1996, 8:216-222.
13. Pasteris NG, Cadle A, Logie LJ, Porteous MEM, Glover TW, Wilroy RS, et al.: Isolation and characterisation of the faciogenital dysplasia (Aarskog-Scott Syndrome) gene: a putative Rho/ Rac guanine nucleotide exchange factor. Cell 1994, 79:669-678.
14. Zmuidzinas A, Fischer K-D, Lira SA, Forrester L, Bryant S, Bernstein A, et al.: The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J 1995, 14:1-11.
15. Zheng Y, Olson MF, Hall A, Cerione RA, Toksoz D: Direct involvement of the small GTP-binding protein Rho in lbc oncogene function. J Biol Chem 1995, 270:9031-9034.
16. Hart MJ, Eva A, Evans T, Aaronson SA, Cerione RA: Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product. Nature 1991, 354:311-314.
17. Hart MJ, Eva A, Zangrilli D, Aaronson SA, Evans T, Cerione RA, et al.: Cellular transformation and guanine nucleotide exchange activity are catalyzed by a common domain on the dbl oncogene product. J Biol Chem 1994, 269:62-65.
18. Yaku H, Sasaki T, Takai Y: The Dbl oncogene product as a GDP/ GTP exchange protein for the Rho family: its properties in comparison with those of Smg GDS. Biochem Biophys Res Commun 1994, 198:811-817.
19. Aspenstrom P, Lindberg U, Hall A: Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol 1996, 6:70-75.
20. Kolluri R, Fuchs Tolias K, Carpenter C, Rosen FS, Kirchhausen T: Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc Natl Acad Sci USA 1996, 93:5615-5618.
21. Symons M, Derry JMJ, Karlak B, Jang S, Lemahieu V, McCormick F, et al.: Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs is implicated in actin polymerization. Cell 1996, 84:723-734.
22. Gulbins E, Coggeshall KM, Baier G, Katzav S, Burn P, Altman A: Tyrosine kinase stimulated guanine nucleotide exchange activity of vav in T cell activation. Science 1993, 260:822-825.
23. Gulbins E, Coggeshall KM, Baier G, Telford D, Langlet C, Baier BG, et al.: Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol 1994, 14:4749-4758.
24. Gulbins E, Langlet C, Baier G, Bonnefoy BN, Herbert E, Altman A, et al.: Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells. J Immunol 1994, 152:2123-2129.
25. Gulbins E, Coggeshall KM, Langlet C, Baier G, Bonnefoy BN, Burn P, et al.: Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol Cell Biol 1994, 14:906-913.
26. Gulbins E, Schlottmann K, Brenner B, Lang F, Coggeshall KM: Molecular analysis of Ras activation bytyrosine phosphorylated Vav. Biochem Biophys Res Commun 1995, 217:876-885.
27. Khosravi-Far R, Chrzanowska WM, Solski PA, Eva A, Burridge K, Der CJ: Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol Cell Biol 1994, 14:6848-6857.
28. Bustelo XR, Suen KL, Leftheris K, Meyers CA, Barbacid M: Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/ GTP exchange factor. Oncogene 1994, 9:2405-2413.
29. Holsinger LJ, Spencer DM, Austin DJ, Schreiber SL, Crabtree GR: Signal transduction in T lymphocytes using a conditional allele of Sos. Proc Natl Acad Sci USA 1995, 92:9810-9814.
30. Clevenger CV, Ngo W, Sokol DL, Luger SM, Gewirtz AM: Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J Biol Chem 1995, 270:13246-13253.
31. Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M, Barbacid M, et al:: Rac-1 dependent stimulation of the JNK/ SAPK signaling pathway by Vav. Oncogene 1996, 13:455-460.
32. Grier RE, Farrington FH, Kendig R, Mamunes P: Autosomal dominant inheritance of the Aarskog syndrome. Am J Med Genet 1983, 15:39-46.
33. Fryns JP: Aarskog syndrome: the changing phenotype with age. Am J Med Genet 1992, 43:420-427.
34. van Leeuwen FN, van der Kammen RA, Habets GGM, Collard JG: Oncogenic activity of TIAM1 and Rac1 in NIH3T3 cells. Oncogene 1995, 11:2215-2221.
35. Guo CH, Janovick JA, Kuphal D, Conn PM: Transient transfection of GGH3-1' cells [GH3 cells stably transfected with the gonadotropin-releasing hormone (GnRH) receptor complementary deoxyribonucleic acid] with the carboxyl-terminal of betaadrenergic receptor kinase 1 blocks prolactin release: evidence for a role of the G protein beta gamma-subunit complex in GnRH signal transduction. Endocrinology 1995, 136:3031-3036.
36. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press; 1989.
37. Howe LR, Leevers SJ, Gomez N, Nakielny S, Cohen P, Marshall CJ: Activation of the MAP kinase pathway by the protein kinase raf. Cell 1992, 71:335-342.